- Home
- FPAY vs CASI Comparison
FPAY vs CASI Comparison
Compare FPAY & CASI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FPAY
- CASI
- Stock Information
- Founded
- FPAY 2003
- CASI 1991
- Country
- FPAY United States
- CASI China
- Employees
- FPAY N/A
- CASI N/A
- Industry
- FPAY Diversified Commercial Services
- CASI Biotechnology: Pharmaceutical Preparations
- Sector
- FPAY Consumer Discretionary
- CASI Health Care
- Exchange
- FPAY Nasdaq
- CASI Nasdaq
- Market Cap
- FPAY 31.0M
- CASI 29.7M
- IPO Year
- FPAY N/A
- CASI 1996
- Fundamental
- Price
- FPAY $1.36
- CASI $1.91
- Analyst Decision
- FPAY Strong Buy
- CASI Strong Buy
- Analyst Count
- FPAY 2
- CASI 1
- Target Price
- FPAY $3.25
- CASI $4.00
- AVG Volume (30 Days)
- FPAY 46.0K
- CASI 7.5K
- Earning Date
- FPAY 05-20-2025
- CASI 05-27-2025
- Dividend Yield
- FPAY N/A
- CASI N/A
- EPS Growth
- FPAY N/A
- CASI N/A
- EPS
- FPAY N/A
- CASI N/A
- Revenue
- FPAY $139,800,732.00
- CASI $28,537,000.00
- Revenue This Year
- FPAY $12.05
- CASI N/A
- Revenue Next Year
- FPAY N/A
- CASI N/A
- P/E Ratio
- FPAY N/A
- CASI N/A
- Revenue Growth
- FPAY 19.51
- CASI N/A
- 52 Week Low
- FPAY $0.97
- CASI $1.64
- 52 Week High
- FPAY $2.37
- CASI $7.67
- Technical
- Relative Strength Index (RSI)
- FPAY 54.81
- CASI 46.41
- Support Level
- FPAY $1.31
- CASI $1.81
- Resistance Level
- FPAY $1.43
- CASI $1.95
- Average True Range (ATR)
- FPAY 0.09
- CASI 0.10
- MACD
- FPAY 0.01
- CASI 0.00
- Stochastic Oscillator
- FPAY 50.00
- CASI 61.36
About FPAY FlexShopper Inc.
FlexShopper Inc is a financial technology company engaged in providing certain types of durable goods to consumers on a lease-to-own basis and providing lease-to-own (LTO) terms to consumers of third-party retailers and e-tailers. Its products include electronics, computers, furniture, mattresses, cameras and camcorders, audio, musical instruments, health, fitness and sports, video games, homes, gardens and tools, appliances, and vacuums on a payment, lease basis. The firm generates a majority of its revenue by leasing its products. The company enables consumers utilizing its e-commerce marketplace to shop for brand-name electronics, home furnishings, and other durable goods on a lease-to-own (LTO) basis.
About CASI CASI Pharmaceuticals Inc.
CASI Pharmaceuticals Inc is a biopharmaceutical company that focuses on commercializing therapeutics and pharmaceutical products. The products include injections for patients who are suffering from leukemias and lymphomas. The EVOMELA injection is used as a conditioning treatment before autologous stem cell transplant for patients with multiple myeloma. The company products include CID-103, CNCT19, EVOMELA, MARQIBO, ZEVALIN, ENMD-2076 and others. The majority of the revenue is generated from the product sales of EVOMELA.